+91 98179 61104 (Bhiwani)
+91 87081 53424 (Uklana)
+91 81990 00279 (Hisar)
+91 96820 09300 (Hansi)
+91 96820 09400 (Hansi)
+91 96820 09500 (Hansi)


Chronic kidney disease (CKD) affects millions of people worldwide, often progressing silently for years before symptoms appear. Understanding the stages of CKD is essential for patients, caregivers, and anyone concerned about kidney health. If you are looking for expert guidance on kidney-related conditions, consulting the Best Urologist Doctor in Hansi can help with timely diagnosis, appropriate treatment, and long-term kidney care. This guide breaks down each stage in detail, explains the key measurements doctors use, and outlines what you can expect at every point along the disease’s progression.
Chronic kidney disease is a long-term condition in which the kidneys gradually lose their ability to filter waste and excess fluid from the blood. Unlike acute kidney injury, which happens suddenly, CKD develops slowly — often over many years — and is classified into five distinct stages based on how well the kidneys are functioning.
The two main markers doctors use to determine the stages of CKD are GFR (Glomerular Filtration Rate) and the presence of protein in the urine, known as albuminuria. Together, these values give a clear picture of kidney health and help guide treatment decisions.
GFR (Glomerular Filtration Rate) measures how much blood the kidneys filter per minute. It’s calculated using a formula that factors in blood creatinine levels, age, sex, and sometimes race or body size. A healthy GFR is typically above 90 mL/min/1.73m², while a declining GFR signals progressively worsening kidney function.
Because GFR can’t be measured directly without specialized testing, doctors rely on estimated GFR (eGFR), derived from a simple blood test measuring creatinine — a waste product produced by muscle metabolism that healthy kidneys filter out efficiently. When kidney function declines, creatinine builds up in the blood, signaling reduced filtering capacity.
Tracking creatinine and GFR over time allows doctors to monitor whether kidney disease is stable, improving, or progressing — and it forms the backbone of the Stage 1-5 classification system used worldwide.

In Stage 1, GFR is normal or even elevated (90 or above), but there is evidence of kidney damage — most often detected through albuminuria (proteinuria), or protein leaking into the urine. At this stage, most people have no symptoms at all, and the disease is usually discovered incidentally during routine blood or urine testing.
Management at this stage focuses on identifying and controlling the underlying cause, such as diabetes or high blood pressure, since these are the two leading contributors to kidney damage. Regular monitoring of GFR and urine protein levels is critical to catching further decline early.
Stage 2 is defined by a GFR between 60 and 89, combined with some sign of kidney damage such as albuminuria (proteinuria), structural abnormalities, or genetic kidney conditions. Like Stage 1, symptoms are typically absent or very mild.
This stage is a critical window for lifestyle intervention. Blood pressure control, blood sugar management, a kidney-friendly diet, and avoiding nephrotoxic medications (like certain pain relievers) can significantly slow progression. Doctors will continue tracking creatinine levels and may recommend more frequent check-ins depending on risk factors.
Stage 3 is often split into two sub-stages:
This is typically when symptoms begin to emerge — fatigue, swelling in the hands or feet, changes in urination patterns, and back pain are common complaints. Albuminuria (proteinuria) often becomes more pronounced, and doctors may begin screening for related complications like anemia, bone disease, and high blood pressure.
At this point, referral to a nephrologist (kidney specialist) is common practice. Dietary adjustments become more important, including monitoring sodium, potassium, and phosphorus intake, and medications may be added to manage blood pressure and protect remaining kidney function.
In Stage 4, GFR falls between 15 and 29, indicating severe and often irreversible kidney damage. Symptoms become more noticeable and may include significant fatigue, nausea, muscle cramps, difficulty concentrating, and fluid retention.
This stage requires close medical supervision. Patients typically begin preparing for the possibility of kidney failure, which includes education about dialysis options (hemodialysis or peritoneal dialysis) and evaluation for a kidney transplant. Doctors closely track creatinine, electrolyte levels, and other markers to time interventions appropriately and delay the need for renal replacement therapy as long as safely possible.
Stage 5, also known as ESRD (End-Stage Renal Disease), is diagnosed when GFR drops below 15. At this point, the kidneys can no longer adequately filter waste and fluid, and the condition becomes life-threatening without treatment.
Patients with ESRD (End-Stage Renal Disease) require either dialysis or a kidney transplant to survive. Symptoms at this stage can be severe: extreme fatigue, shortness of breath, swelling throughout the body, confusion, and a buildup of toxins that can affect nearly every organ system. Coordinated care among nephrologists, dietitians, and transplant teams becomes essential for managing quality of life and long-term outcomes.

Diagnosing and staging CKD relies primarily on two tests:
These two values are combined in what’s often called the “KDIGO heat map” — a grid used by nephrologists to categorize risk based on both GFR and albuminuria levels simultaneously. A person with a lower GFR and higher albuminuria faces a greater risk of progression toward ESRD (End-Stage Renal Disease) than someone with only one risk factor.
Because early-stage CKD often has no symptoms, routine screening is particularly important for high-risk groups — including those with diabetes, hypertension, a family history of kidney disease, or age over 60.
While CKD is often progressive, its course is not always inevitable. Several strategies can help slow decline at any stage:
Most primary care physicians can manage early CKD, but referral to a nephrologist is generally recommended once GFR falls below 30, or earlier if albuminuria (proteinuria) is significant, if the underlying cause is unclear, or if the disease is progressing rapidly. Early specialist involvement has been shown to improve outcomes and delay progression toward ESRD (End-Stage Renal Disease).
Understanding the stages of CKD empowers patients to take an active role in their care. From Stage 1’s subtle warning signs to Stage 5’s life-sustaining treatments, each phase reflects a measurable decline in kidney function — tracked primarily through GFR and creatinine levels, alongside albuminuria (proteinuria). For patients managing advanced kidney disease or related surgical conditions, consulting a General Surgeon Doctor in Hansi can be an important part of comprehensive care when surgical evaluation is required. Early detection, consistent monitoring, and proactive lifestyle and medical management can make a meaningful difference in slowing progression and preserving quality of life, even for those facing ESRD (End-Stage Renal Disease).